T Man Pharmaceutical PCL

T Man Pharmaceutical PCL

TMAN · BK · Healthcare / Drug Manufacturers - Specialty & Generic

10.20THB+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close10.20
Open10.10
Day Range10.00 – 10.20
52-Week Range9.47 – 12.95
Volume69.39K
Market Cap4.20B
P/E (TTM)8.33
Forward P/E0.00
EPS1.26
Dividend Yield5.33%
50-Day Avg10.62
200-Day Avg11.41

About

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and traditional medicines, dietary supplements, vitamins and minerals, skin care and aesthetics, whey protein, and mommy and kid products, as well as cosmetics, modern medicines, mossi guard, nevtral, propolis, and vita-c products. In addition, it offers products under various brand names, such as Iyara, Propoliz, POLAR, and Fibermate. The company also exports its products. Further, the company offers original equipment manufacturing services. Additionally, it offers medicines in the form of tablets, capsules, powders, liquids, and semisolids. The company also exports its products. T.Man Pharmaceutical Public Company Limited was founded in 1991 and is based in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Prapon Thanachotipan
  • Employees0
  • Headquarters69/1 Soi Bang Khun Thian 14, Bangkok, Thailand, 10150, Thailand
  • Websitehttps://www.tmanpharmaceutical.com

Leadership

  • Mr. Prapon ThanachotipanCEO, Acting Chief Sales Officer, Acting Chief Marketing Officer & Director · b. 1982
  • Ms. Orapan ThanachotipanDeputy CEO of Financial, Accounting & Administration & Director · b. 1981
  • Ms. Benjawan ThanachotipanDeputy CEO of International Sales and Director · b. 1987
  • Ms. Siriwan ThanachotipanDeputy Chief Executive Officer of Research & Development and Director · b. 1984
  • Ms. Darika TaengtrongCFO & Company Secretary · b. 1983
  • Mr. Tras ObsuwanCOO & Head of Investor Relation · b. 1987
  • Mr. Bordin ThumacheewanskulCompliance Officer · b. 1989
  • Mr. Wattana ChannakhinHead of Internal Audit · b. 1979
  • Ms. Pempichanan ThanachotipanChief Procurement Officer · b. 1985
  • Mr. Varitthorn SiripraphatmongkhonChief Engineering Officer · b. 1984

Financials

Income Statement

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Total Revenue2.02B1.97B2.21B2.51B
Growth (%)--2.20%+12.19%+13.26%
Cost of Revenue923.57M1.00B1.13B1.34B
Gross Profit1.09B969.02M1.08B1.17B
Gross Margin54.20%49.13%48.81%46.60%
Operating Expense492.88M451.80M543.35M603.04M
Operating Income600.15M517.22M536.64M564.85M
Operating Margin29.76%26.23%24.25%22.54%
EBITDA683.30M622.91M654.81M768.36M
EBITDA Margin33.88%31.58%29.59%30.66%
Net Income472.82M431.09M450.70M523.07M
Net Income Margin23.45%21.86%20.37%20.87%
Interest Expense16.98M14.85M18.63M28.44M
Interest Expense % of Total Revenue0.84%0.75%0.84%1.13%

Balance Sheet

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Total Assets2.28B2.63B3.46B3.78B
Total Liabilities1.24B1.11B1.69B1.67B
Total Equity1.04B1.52B1.77B2.12B
Cash307.17M348.04M448.38M399.31M
Net Debt282.91M188.47M631.62M475.69M

Cash Flow

Currency: THB2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow523.53M282.09M519.66M336.44M
Financing Cash Flow-61.19M-24.85M301.72M-416.63M
Capital Expenditure234.52M219.95M173.95M226.44M
Free Cash Flow289.02M62.15M345.71M110.00M
Dividends Paid011.83M1.34B175.91M
FCF to OCF55.20%22.03%66.53%32.70%
Dividend Paid to FCF0.00%19.03%386.35%159.92%

Earnings

Report DateNov 11, 2024Feb 25, 2025May 14, 2025Jun 30, 2025Nov 12, 2025Feb 27, 2026May 13, 2026Aug 19, 2026
EPS Estimate0.26-0.29-0.280.310.29-
EPS Actual0.310.270.300.270.280.460.290.24
Surprise19.23%-3.45%-0.54%48.39%0.00%-
TimingAfter-hoursPre-marketPre-market--Pre-marketAfter-hours-

Key Statistics & Ratios

Market Cap4.20B
Enterprise Value4.28B
Trailing P/E8.33
Forward P/E0.00
Price / Sales1.60
Price / Book1.91
EPS1.26
Book Value5.50
Revenue (TTM)2.62B
Gross Profit (TTM)1.19B
EBITDA695.31M
Profit Margin19.34%
Operating Margin20.47%
Return on Equity24.59%
Return on Assets9.65%
Shares Outstanding400.00M
Shares Float86.47M
Dividend Yield5.33%
Dividend Rate0.56
Payout Ratio43.91%

Dividends

20262×
0.24Aug 26, 20260.32May 8, 2026
20252×
0.24Aug 26, 20250.20May 6, 2025